These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 2873595)
1. Effect of omeprazole on gastric acid secretion by the rat isolated stomach. Coruzzi G; Adami M; Moretti U; Bertaccini G Pharmacol Res Commun; 1986 Mar; 18(3):257-71. PubMed ID: 2873595 [TBL] [Abstract][Full Text] [Related]
2. Rat gastric secretion "in vitro": interaction between histamine and various antisecretagogues acting by different mechanisms. Coruzzi G; Adami M; Bertaccini G; Canfield SP Pharmacol Res Commun; 1985 Nov; 17(11):1027-41. PubMed ID: 4089008 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of action of omeprazole--a survey of its inhibitory actions in vitro. Wallmark B; Lorentzon P; Larsson H Scand J Gastroenterol Suppl; 1985; 108():37-51. PubMed ID: 2988109 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of Na+, K(+)-ATPase inhibition by ouabain on acid secretory responses to histamine and bethanechol in the mouse isolated stomach. Horie S; Yano S; Watanabe K Br J Pharmacol; 1994 May; 112(1):87-92. PubMed ID: 8032667 [TBL] [Abstract][Full Text] [Related]
5. Animal pharmacodynamics of omeprazole. A survey of its pharmacological properties in vivo. Larsson H; Mattson H; Sundell G; Carlsson E Scand J Gastroenterol Suppl; 1985; 108():23-35. PubMed ID: 3858975 [TBL] [Abstract][Full Text] [Related]
6. Gastric antisecretory activity of lansoprazole in different experimental models: comparison with omeprazole. Coruzzi G; Adami M; Bertaccini G Gen Pharmacol; 1995 Sep; 26(5):1027-32. PubMed ID: 7557245 [TBL] [Abstract][Full Text] [Related]
7. Differences in the antisecretory actions of the proton pump inhibitor AG-1749 (lansoprazole) and the histamine H2-receptor antagonist famotidine in rats and dogs. Nagaya H; Inatomi N; Satoh H Jpn J Pharmacol; 1991 Apr; 55(4):425-36. PubMed ID: 1886288 [TBL] [Abstract][Full Text] [Related]
8. Inhibitory action of omeprazole on acid formation in gastric glands and on H+,K+-ATPase isolated from human gastric mucosa. Elander B; Fellenius E; Leth R; Olbe L; Wallmark B Scand J Gastroenterol; 1986 Apr; 21(3):268-72. PubMed ID: 3012768 [TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of omeprazole. Wallmark B Scand J Gastroenterol Suppl; 1986; 118():11-7. PubMed ID: 3014640 [TBL] [Abstract][Full Text] [Related]
10. The anti-secretory and anti-ulcer activities of esomeprazole in comparison with omeprazole in the stomach of rats and rabbits. Bastaki SM; Chandranath IS; Singh J Mol Cell Biochem; 2008 Feb; 309(1-2):167-75. PubMed ID: 18044010 [TBL] [Abstract][Full Text] [Related]
11. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo. Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936 [TBL] [Abstract][Full Text] [Related]
12. Some profiles of transmucosal potential difference in rat stomach determined in situ with special reference to effects of timoprazole, a H+,K+-ATPase inhibitor. Yano S; Katsuyama Y; Watanabe K Jpn J Pharmacol; 1986 Oct; 42(2):209-16. PubMed ID: 2879056 [TBL] [Abstract][Full Text] [Related]
13. Effects of omeprazole and cimetidine on gastric acid secretion and right atrial beating frequency in isolated organ preparations from the guinea pig. Larsson H; Carlsson E; Sundell G Digestion; 1984; 29(1):12-8. PubMed ID: 6327439 [TBL] [Abstract][Full Text] [Related]
14. Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion. Tanaka S; Akiba Y; Kaunitz JD Gut; 1998 Sep; 43(3):334-41. PubMed ID: 9863477 [TBL] [Abstract][Full Text] [Related]
15. Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells. Inoie M; Marubuchi S; Arai H Jpn J Pharmacol; 1998 Nov; 78(3):313-22. PubMed ID: 9869265 [TBL] [Abstract][Full Text] [Related]
16. Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist. Makovec F; Revel L; Letari O; Mennuni L; Impicciatore M Eur J Pharmacol; 1999 Mar; 369(1):81-90. PubMed ID: 10204685 [TBL] [Abstract][Full Text] [Related]
17. Gastric antisecretory effects of esaprazole in rats. Blandizzi C; Natale G; De Bona M; Del Tacca M Digestion; 1992; 51(4):226-32. PubMed ID: 1356865 [TBL] [Abstract][Full Text] [Related]
18. Effect of substituted benzimidazoles on acid secretion in isolated and enriched guinea pig parietal cells. Sewing KF; Harms P; Schulz G; Hannemann H Gut; 1983 Jun; 24(6):557-60. PubMed ID: 6303916 [TBL] [Abstract][Full Text] [Related]
19. Histamine and duodenal ulcer: effect of omeprazole on gastric histamine in patients with duodenal ulcer. Man WK; Thompson JN; Baron JH; Spencer J Gut; 1986 Apr; 27(4):418-22. PubMed ID: 2420686 [TBL] [Abstract][Full Text] [Related]
20. Effects of drugs acting on Cl(-)-HCO3- and Na(+)-H+ exchangers on acid secretion in the rat gastric mucosa sheet preparation. Horie S; Yano S; Watanabe K Eur J Pharmacol; 1992 Dec; 229(1):15-9. PubMed ID: 1361914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]